Temozolomide and Glioblastoma multiforme - a phase IV clinical study of FDA data
Summary:
Glioblastoma multiforme is found among people who take Temozolomide, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Temozolomide and have Glioblastoma multiforme. It is created by eHealthMe based on reports of 15,459 people who have side effects when taking Temozolomide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
15,459 people reported to have side effects when taking Temozolomide.
Among them, 112 people (0.72%) have Glioblastoma multiforme.
What is Temozolomide?
Temozolomide has active ingredients of temozolomide. It is often used in glioblastoma multiforme. eHealthMe is studying from 15,505 Temozolomide users for its effectiveness, alternative drugs and more.
What is Glioblastoma multiforme?
Glioblastoma multiforme (most common and deadliest of malignant primary brain tumours in adults) is found to be associated with 585 drugs and 326 conditions by eHealthMe.
Number of Temozolomide and Glioblastoma multiforme reports submitted per year:
Time on Temozolomide when people have Glioblastoma multiforme *:
Gender of people who have Glioblastoma multiforme when taking Temozolomide*:
Age of people who have Glioblastoma multiforme when taking Temozolomide *:
Common drugs people take besides Temozolomide *:
Common side effects people have besides Glioblastoma multiforme *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Temozolomide and have Glioblastoma multiforme?
Check whether Glioblastoma multiforme is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Glioblastoma multiforme and when was it recovered:
Expand to all the drugs that have ingredients of temozolomide:
Alternative drugs to, pros and cons of Temozolomide:
- Temozolomide (15,505 reports)
Common Temozolomide side effects:
- Thrombocytopenia (decrease of platelets in blood): 1,887 reports
- Death: 998 reports
- Fatigue (feeling of tiredness): 881 reports
- Nausea and vomiting: 803 reports
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 789 reports
Browse all side effects of Temozolomide:
a b c d e f g h i j k l m n o p q r s t u v w x y zGlioblastoma multiforme treatments and more:
- Glioblastoma multiforme (6,131 reports)
COVID vaccines that are related to Glioblastoma multiforme:
- Glioblastoma multiforme in Moderna COVID Vaccine
- Glioblastoma multiforme in Pfizer BioNTech Covid Vaccine
- Glioblastoma multiforme in Johnson and Johnson Covid Vaccine
Common drugs associated with Glioblastoma multiforme:
- Temozolomide: 112 reports
All the drugs that are associated with Glioblastoma multiforme:
- Glioblastoma multiforme (585 drugs)
All the conditions that are associated with Glioblastoma multiforme:
- Glioblastoma multiforme (326 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on temozolomide (the active ingredients of Temozolomide) and Temozolomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lupkynis and Triamcinolone Acetonide drug interaction - now
- Tecfidera vs. Rituxan - 8 seconds ago
- Ritalin and Irbesartan drug interaction - 18 seconds ago
- Temozolomide and Glioblastoma Multiforme - 25 seconds ago
- Terbinafine Hydrochloride and Visual Impairment - 27 seconds ago
- Methylphenidate and Chronic Kidney Disease - 34 seconds ago
- Tamoxifen Citrate and Mood Swings - 37 seconds ago
- Novolin N and Impaired Gastric Emptying - 40 seconds ago
- Sucralfate and Eyelids Pruritus - 41 seconds ago
- Nph Purified Pork Isophane Insulin and Fatigue Aggravated - 57 seconds ago